Skip to content
2000
Volume 16, Issue 23
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Tobacco smoking is the most important preventable cause of cardiovascular disease. In this paper we review current epidemiological and pathophysiological evidence linking smoking with cardiovascular and metabolic diseases. Among the effects of smoking there is the alteration of lipid metabolism through the increase in lipolysis, insulin resistance and tissue lipotoxicity. Smoking is both prothrombotic and atherogenic. As an effect, the risk of acute myocardial infarction, sudden cardiac death, stroke, aortic aneurysm and peripheral vascular disease is increased. Even very low doses of exposure increase the risk of cardiovascular disease (CVD) and metabolic alterations. On the other hand, smoking cessation restores, at least in part, lipid metabolism and the benefits can be observed already after a short period of abstinence from smoking, although it occurs several years before the risks approach those of the never-smoker.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161210792062858
2010-08-01
2025-05-06
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161210792062858
Loading

  • Article Type:
    Research Article
Keyword(s): Insulin resistance; lipolysi; nicotine; tobacco smoking
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test